AZN logo

AstraZeneca (AZN) Cash from operations

annual CFO:

$11.86B+$1.52B(+14.65%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AZN annual cash flow from operations is $11.86 billion, with the most recent change of +$1.52 billion (+14.65%) on December 31, 2024.
  • During the last 3 years, AZN annual CFO has risen by +$5.90 billion (+98.91%).
  • AZN annual CFO is now at all-time high.

Performance

AZN Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

quarterly CFO:

$3.71B+$806.00M(+27.73%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AZN quarterly cash flow from operations is $3.71 billion, with the most recent change of +$806.00 million (+27.73%) on March 31, 2025.
  • Over the past year, AZN quarterly CFO has increased by +$1.23 billion (+49.36%).
  • AZN quarterly CFO is now -9.04% below its all-time high of $4.08 billion, reached on December 31, 2009.

Performance

AZN quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

TTM CFO:

$13.09B+$1.23B(+10.34%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AZN TTM cash flow from operations is $13.09 billion, with the most recent change of +$1.23 billion (+10.34%) on March 31, 2025.
  • Over the past year, AZN TTM CFO has increased by +$3.39 billion (+34.96%).
  • AZN TTM CFO is now at all-time high.

Performance

AZN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AZN Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.7%+49.4%+35.0%
3 y3 years+98.9%+14.9%+80.3%
5 y5 years+299.5%+2571.2%+274.5%

AZN Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+98.9%at high+197.5%at high+80.3%
5 y5-yearat high+299.5%at high+2571.2%at high+274.5%
alltimeall timeat high+5650.2%-9.0%+476.2%at high+2812.2%

AZN Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$3.71B(+27.7%)
$13.09B(+10.3%)
Dec 2024
$11.86B(+14.7%)
$2.91B(-14.1%)
$11.86B(+4.6%)
Sep 2024
-
$3.38B(+9.7%)
$11.33B(+2.4%)
Jun 2024
-
$3.08B(+24.1%)
$11.06B(+14.1%)
Mar 2024
-
$2.49B(+4.5%)
$9.70B(-6.3%)
Dec 2023
$10.35B(+5.5%)
$2.38B(-23.6%)
$10.35B(-0.2%)
Sep 2023
-
$3.11B(+81.3%)
$10.36B(+1.8%)
Jun 2023
-
$1.72B(-45.2%)
$10.18B(+4.8%)
Mar 2023
-
$3.13B(+30.7%)
$9.71B(-1.0%)
Dec 2022
$9.81B(+64.5%)
$2.40B(-18.2%)
$9.81B(+11.1%)
Sep 2022
-
$2.93B(+134.8%)
$8.83B(+15.9%)
Jun 2022
-
$1.25B(-61.4%)
$7.62B(+4.9%)
Mar 2022
-
$3.23B(+127.9%)
$7.26B(+21.8%)
Dec 2021
$5.96B(+24.3%)
$1.42B(-17.5%)
$5.96B(-6.0%)
Sep 2021
-
$1.72B(+92.7%)
$6.34B(-1.6%)
Jun 2021
-
$892.00M(-53.9%)
$6.45B(-2.2%)
Mar 2021
-
$1.93B(+7.6%)
$6.59B(+37.4%)
Dec 2020
$4.80B(+61.6%)
$1.80B(-1.3%)
$4.80B(+9.7%)
Sep 2020
-
$1.82B(+75.2%)
$4.38B(+19.7%)
Jun 2020
-
$1.04B(+648.2%)
$3.66B(+4.6%)
Mar 2020
-
$139.00M(-89.9%)
$3.50B(+17.7%)
Dec 2019
$2.97B(+13.4%)
$1.38B(+24.7%)
$2.97B(-22.2%)
Sep 2019
-
$1.10B(+25.6%)
$3.82B(+19.9%)
Jun 2019
-
$878.00M(-326.9%)
$3.18B(+34.3%)
Mar 2019
-
-$387.00M(-117.4%)
$2.37B(-9.4%)
Dec 2018
$2.62B(-26.8%)
$2.22B(+374.2%)
$2.62B(+88.2%)
Sep 2018
-
$469.00M(+621.5%)
$1.39B(-56.1%)
Jun 2018
-
$65.00M(-146.4%)
$3.17B(-5.5%)
Mar 2018
-
-$140.00M(-114.0%)
$3.35B(-6.4%)
Dec 2017
$3.58B(-13.7%)
$997.00M(-55.6%)
$3.58B(-21.2%)
Sep 2017
-
$2.24B(+797.2%)
$4.54B(+46.1%)
Jun 2017
-
$250.00M(+184.1%)
$3.11B(+2.3%)
Mar 2017
-
$88.00M(-95.5%)
$3.04B(-26.7%)
Dec 2016
$4.14B(+24.7%)
$1.96B(+141.7%)
$4.14B(+50.4%)
Sep 2016
-
$811.00M(+348.1%)
$2.76B(-25.3%)
Jun 2016
-
$181.00M(-84.8%)
$3.69B(-19.6%)
Mar 2016
-
$1.19B(+108.9%)
$4.59B(+38.1%)
Dec 2015
$3.32B(-52.9%)
$571.00M(-67.3%)
$3.32B(-27.7%)
Sep 2015
-
$1.75B(+61.6%)
$4.59B(-4.3%)
Jun 2015
-
$1.08B(-1600.0%)
$4.80B(-17.2%)
Mar 2015
-
-$72.00M(-103.9%)
$5.80B(-17.8%)
Dec 2014
$7.06B(-4.6%)
$1.84B(-5.5%)
$7.06B(-8.3%)
Sep 2014
-
$1.95B(-6.2%)
$7.69B(+12.1%)
Jun 2014
-
$2.08B(+75.1%)
$6.86B(+7.4%)
Mar 2014
-
$1.19B(-52.1%)
$6.39B(-13.7%)
Dec 2013
$7.40B(+6.5%)
$2.48B(+121.6%)
$7.40B(-4.8%)
Sep 2013
-
$1.12B(-30.4%)
$7.77B(-2.4%)
Jun 2013
-
$1.61B(-26.9%)
$7.96B(+4.7%)
Mar 2013
-
$2.20B(-22.8%)
$7.61B(+9.5%)
Dec 2012
$6.95B(-11.2%)
$2.85B(+117.6%)
$6.95B(-3.1%)
Sep 2012
-
$1.31B(+4.6%)
$7.17B(-7.9%)
Jun 2012
-
$1.25B(-18.8%)
$7.78B(+4.2%)
Mar 2012
-
$1.54B(-49.8%)
$7.47B(-4.5%)
Dec 2011
$7.82B
$3.07B(+59.6%)
$7.82B(-5.9%)
Sep 2011
-
$1.92B(+104.8%)
$8.31B(-4.9%)
DateAnnualQuarterlyTTM
Jun 2011
-
$939.00M(-50.3%)
$8.74B(-19.3%)
Mar 2011
-
$1.89B(-46.9%)
$10.83B(+1.4%)
Dec 2010
$10.68B(-9.0%)
$3.56B(+51.3%)
$10.68B(-4.7%)
Sep 2010
-
$2.35B(-22.3%)
$11.20B(+0.3%)
Jun 2010
-
$3.03B(+74.1%)
$11.17B(-0.7%)
Mar 2010
-
$1.74B(-57.4%)
$11.25B(-4.2%)
Dec 2009
$11.74B(+34.3%)
$4.08B(+75.7%)
$11.74B(+12.4%)
Sep 2009
-
$2.32B(-25.2%)
$10.45B(+6.8%)
Jun 2009
-
$3.11B(+39.5%)
$9.78B(+14.1%)
Mar 2009
-
$2.23B(-20.2%)
$8.58B(-1.9%)
Dec 2008
$8.74B(+16.4%)
$2.79B(+68.2%)
$8.74B(-2.3%)
Sep 2008
-
$1.66B(-12.7%)
$8.95B(+3.8%)
Jun 2008
-
$1.90B(-20.5%)
$8.62B(+11.7%)
Mar 2008
-
$2.39B(-20.2%)
$7.71B(+2.7%)
Dec 2007
$7.51B(-2.4%)
$3.00B(+125.8%)
$7.51B(+12.6%)
Sep 2007
-
$1.33B(+33.2%)
$6.67B(-10.5%)
Jun 2007
-
$997.00M(-54.4%)
$7.46B(-10.9%)
Mar 2007
-
$2.19B(+1.3%)
$8.37B(+8.8%)
Dec 2006
$7.69B(+14.1%)
$2.16B(+2.3%)
$7.69B(+3.1%)
Sep 2006
-
$2.11B(+10.6%)
$7.46B(+6.4%)
Jun 2006
-
$1.91B(+26.3%)
$7.01B(+3.9%)
Mar 2006
-
$1.51B(-21.6%)
$6.75B(+0.0%)
Dec 2005
$6.74B(+40.0%)
$1.93B(+16.2%)
$6.74B(-1.3%)
Sep 2005
-
$1.66B(+0.9%)
$6.83B(+8.7%)
Jun 2005
-
$1.65B(+9.0%)
$6.29B(+24.7%)
Mar 2005
-
$1.51B(-25.2%)
$5.04B(+4.7%)
Dec 2004
$4.82B(+43.0%)
$2.02B(+80.8%)
$4.82B(+59.4%)
Sep 2004
-
$1.12B(+178.3%)
$3.02B(+2.3%)
Jun 2004
-
$401.00M(-68.7%)
$2.95B(-15.3%)
Mar 2004
-
$1.28B(+474.9%)
$3.49B(+3.5%)
Dec 2003
$3.37B(-30.3%)
$223.00M(-78.7%)
$3.37B(-14.2%)
Sep 2003
-
$1.05B(+12.1%)
$3.93B(-7.6%)
Jun 2003
-
$933.92M(-19.8%)
$4.25B(+2.3%)
Mar 2003
-
$1.16B(+49.0%)
$4.15B(-14.1%)
Dec 2002
$4.83B(+54.6%)
$780.92M(-43.0%)
$4.83B(+3.1%)
Sep 2002
-
$1.37B(+63.7%)
$4.69B(+11.3%)
Jun 2002
-
$837.00M(-54.6%)
$4.21B(+13.0%)
Mar 2002
-
$1.84B(+189.6%)
$3.73B(+19.3%)
Dec 2001
$3.13B(+33.8%)
$637.00M(-28.7%)
$3.13B(+108.1%)
Sep 2001
-
$894.00M(+153.9%)
$1.50B(-42.6%)
Jun 2001
-
$352.04M(-71.7%)
$2.62B(-16.3%)
Mar 2001
-
$1.24B(-225.9%)
$3.13B(+34.0%)
Dec 2000
$2.34B(+9.9%)
-$986.91M(-149.1%)
$2.34B(-29.7%)
Sep 2000
-
$2.01B(+133.1%)
$3.32B(+153.2%)
Jun 2000
-
$862.75M(+92.0%)
$1.31B(+192.0%)
Mar 2000
-
$449.42M
$449.42M
Dec 1999
$2.13B(-37.9%)
-
-
Dec 1998
$3.42B(+358.0%)
-
-
Dec 1997
$747.21M(-5.1%)
-
-
Dec 1996
$787.75M(+34.5%)
-
-
Dec 1995
$585.64M(-6.4%)
-
-
Dec 1994
$625.36M(-11.4%)
-
-
Dec 1993
$705.58M(+242.1%)
-
-
Dec 1992
$206.27M(-59.2%)
-
-
Dec 1991
$505.22M(-37.3%)
-
-
Dec 1990
$806.30M
-
-

FAQ

  • What is AstraZeneca annual cash flow from operations?
  • What is the all time high annual CFO for AstraZeneca?
  • What is AstraZeneca annual CFO year-on-year change?
  • What is AstraZeneca quarterly cash flow from operations?
  • What is the all time high quarterly CFO for AstraZeneca?
  • What is AstraZeneca quarterly CFO year-on-year change?
  • What is AstraZeneca TTM cash flow from operations?
  • What is the all time high TTM CFO for AstraZeneca?
  • What is AstraZeneca TTM CFO year-on-year change?

What is AstraZeneca annual cash flow from operations?

The current annual CFO of AZN is $11.86B

What is the all time high annual CFO for AstraZeneca?

AstraZeneca all-time high annual cash flow from operations is $11.86B

What is AstraZeneca annual CFO year-on-year change?

Over the past year, AZN annual cash flow from operations has changed by +$1.52B (+14.65%)

What is AstraZeneca quarterly cash flow from operations?

The current quarterly CFO of AZN is $3.71B

What is the all time high quarterly CFO for AstraZeneca?

AstraZeneca all-time high quarterly cash flow from operations is $4.08B

What is AstraZeneca quarterly CFO year-on-year change?

Over the past year, AZN quarterly cash flow from operations has changed by +$1.23B (+49.36%)

What is AstraZeneca TTM cash flow from operations?

The current TTM CFO of AZN is $13.09B

What is the all time high TTM CFO for AstraZeneca?

AstraZeneca all-time high TTM cash flow from operations is $13.09B

What is AstraZeneca TTM CFO year-on-year change?

Over the past year, AZN TTM cash flow from operations has changed by +$3.39B (+34.96%)
On this page